Inhibiting DYRK1A activated the cardiomyocyte cell cycle and enhanced cardiac repair after MI, with a crucial role played by epigenetic modifications (H3K4me3 and H3K27ac) involving WD repeat-containing protein 82 and lysine acetyltransferase 6A. Here, WDR82 is linked to myocardial infarction.